• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Replies
15
Views
1K
Replies
5
Views
632
Replies
34
Views
7K
Replies
33
Views
5K
Replies
5
Views
1K
Replies
21
Views
505
Replies
2
Views
169